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Оваа статија е со отворен пристап дистрибуирана 
под условите на нелокализирана лиценца, која 
овозможува неограничена употреба, дистрибу-
ција и репродукција на било кој медиум, доколку 
се цитираат оригиналниот(ите) автор(и) и изворот.
Конкурентски интереси: Авторот изјавува дека 
нема конкурентски интереси.
Цитокините (IL-1, IL-6, IL-8, TNF- Alfa) се од исклучително значење во бременоста и тие се продуцираат од 
страна на постелката во амнионската течност и се зголемени доколку постои интраутерина инфламација. 
Целта на студијата беше да се докаже соодносот на покаченото ниво на IL-8 во амнионската течност во по-
четокот на раниот втор триместар (16-22 г.н.) и предвременото породување (< 37 г.н.). Материјал и методи: Во 
оваа проспективна студија беа вклучени 150 гравидни пациентки, каде постоеше медицинска индикација 
за изведување на амниоцентеза (напредната мајчина возраст, висок ризик на PRISCA I, суспектни аномалии 
на фетусот, вирусни инфекции, или по желба на мајката). По потпишана согласност за учество во студија-
та, сите пациентки беа анализирани, односно на сите пациентки им беше направен ехо преглед, вагинална 
цервикометрија, и беа земени дополнителни 5 мл амнионска течност при изведување на амниоцентезата. 
Сите пациентки беа следени сè до нивното породување, каде точно беше нотирана гестациската недела на 
породување, а потоа споредена со нивото на IL-8. Резултати: Сите 150 пациентки беа во периодот од 16-22 
гестациска недела. Кај 20 од вкупно 150 пациентки констатиравме предвремено раѓање, додека, пак, 120 
пациентки се породија во термин. 139 пациентки имаа зачнато природно, додека 9  со ИВФ и ЕТ, од кои три 
се породија предвремено. 80% од пациентките кои се породија предвремено имаа зголемени вредности на 
IL-8. Средната вредност на должина на цервиксот кај оние кои се породија во термин беше 32,1 мм, додека 
кај оние превремено породени беше 30,7 мм. Заклучок: Оваа студија јапотврди оправданоста за испитување 
цитокини како метод за откривање на асимптоматски промени кај пацинтки кое ќе се породат предвремено.
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Cytokines (IL-1, IL-6, IL-8, TNF- alfa) are of crucial importance during pregnancy; they are produced by the 
placenta in the amniotic fluid and they are elevated in case of intrauterine inflammation. The аim of the 
study was to prove the ratio between the increased IL-8 in the amniotic fluid in the beginning of the second 
trimester (16-22 g.w.) and premature birth (< 36.6 g.w.). Material and methods: This was a prospective study 
that included 150 pregnant patients that had clinical indication for amniocentesis (advanced mother’s age, 
abnormal test of PRISCA I, suspicious anomalies of the fetus, virus infection or mother’s wish). They all gave a 
signed consent on being informed about the aims of the study, and following the protocol, they were analyzed 
and examined i.e. all patients underwent ultrasound examination, vaginal cervicometry. Five ml. of amniotic 
fluid during the process of amniocentesis was taken for the purpose of the study. All patients were followed 
until they gave birth, and the exact week of gestation was noted and compered with the IL-8 level. Results: All 
150 patients were in the period of 16th-22nd gestational weeks. Twenty of the total of 150 patients had preterm 
delivery. A total of 139 patients conceived naturally and 9 patients underwent in vitro fertilisation (IVF) and 
embryo transfer (ET). In those with IVF and ET, 3 had preterm birth. 80% of patients that had preterm birth had 
increased IL- 8 levels. Median cervical length in those who gave birth at term was 32.1 mm and in those who 
gave preterm birth was 30.7mm. Conclusion: The study has confirmed the reason for examining cytokines as a 
method of discovering asymptomatic changes in patients who would give a premature birth.
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Intraamniotic fluid infections caused 
by viruses, bacteria or mycoplasmas are 
frequently followed by increased perina-
tal morbidity and mortality. Cytokines 
are key substances regulating a number 
of biological processes including repro-
ductive and inflammatory processes1. 
An association between intraamniotic 
infections, rising concentrations of in-
flammatory cytokines in amniotic flu-
id and preterm labor is often present2. 
Many researches are driven to find reli-
able markers for intraamniotic fluid in-
fections with a high predictive value that 
make possible detection of patients with 
intraamniotic infection3,4.
IL-8 is secreted and is an important me-
diator of the immune reaction in the 
immune system response, IL8 or chemo-
kine (C-X-C motif) ligand 8. CXCL8 is a 
cytokine produced by macrophages and 
other cell types such as epithelial cells 
and endothelial cells5. Endothelial cells 
store IL-8 in their storage vesicles6. In 
humans, the interleukin-8 protein is 
encoded by the CXCL8 gene. IL-8 is ini-
tially produced as a precursor peptide of 
99 amino acids, which then undergoes 
cleavage to create several active IL-8 iso-
forms7.
Interleukin-8 is a key mediator associ-
ated with inflammation where it plays a 
key role in neutrophil recruitment and 
neutrophil degranulation3, 5. As an ex-
ample, it has been cited as a proinflam-
matory mediator in infections linked 
with preterm pregnancies and its pres-
ence in amniotic fluid. 
The presence of IL-8 in amniotic fluid, as 
well as IL-6, suggests these cytokines are 
involved in important immunobiological 
events relevant to the third trimester of 
gestation1, 7.
Fetal development in uncomplicated 
pregnancies occurs in the absence of 
amniotic fluid infections and offspring 
microbial colonization starts after uter-
ine contractions and rupture of amniotic 
membrane, therefore all earlier studies 
have suggested that both uterine cav-
ity and amniotic fluid stay as “sterile 
womb”8.
However, the current evidence for a ster-
ile intrauterine environment is incon-
clusive and the extent to which, if, and 
how maternal infections influence fetal 
immunologic development and the state 
of the infant is not still clear6, 7. There-
fore, this study investigated the presence 
of an IL-8 in amniotic fluid in the second 
trimester of uncomplicated pregnancies 
and determined the amniotic fluid IL-8 
load.
Midtrimester amniocentesis is the most 
widely used procedure for prenatal diag-
nosis of fetal cytogenetic abnormalities. 
However, the fluid and cells obtained at 
the time of the procedure are not cur-
rently being used to assess the risk of oth-
er causes of adverse pregnancy outcomes 
such as preterm birth, fetal growth re-
striction and preeclampsia. Preterm de-
livery occurring after preterm labor is a 
significant cause of neonatal morbidity 
and mortality9.
Antenatal upper genital infection is 
known to be strongly associated with 
preterm labor and delivery. Because such 
infection is often subclinical, intractable 
preterm labor may be the first sign of 
this pathologic process10.
Most women with preterm labor, who 
are later demonstrated to have chorio-
amnionitis, usually have no symptoms 
such as fever, abdominal pain, peripher-
al blood leukocytosis and fetal tachycar-
dia11, 12. Therefore, identifying women 
with intrauterine infections is a major 
challenge.
Different amniotic fluid markers have 
been evaluated to determine intrauter-
ine infection in women with symptoms 
of preterm delivery. Recently, levels of 
many cytokines such as IL-6, IL-8, C-re-
active protein (CRP), matrix metallo-
proteinases-8, angiogenin were studied 
in the amniotic fluid at the time of the 
genetic amniocentesis for prediction of 
preterm delivery13, 14.
The aim of this study was to prove the 
ratio between the increased IL-8 in the 
amniotic fluid in the beginning of the 
second trimester (16-22 g.w.) and prema-
ture birth (< 36, 6g.w.).
Materials and methods 
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7This prospective study was conducted at 
the University Clinic of Gynecology and 
Obstetrics, Ss Cyril and Methodius Uni-
versity, Medical Faculty, Skopje, Republic 
of North Macedonia at the Department of 
High Risk Pregnancy. The study included 
150 pregnant women that had clinical 
indication for amniocentesis (advanced 
mother’s age, abnormal test of PRISCA I, 
suspicious anomalies of the fetus, virus 
infection or mother’s wish), during the 
period fromJ une 2018 to December 2018. 
Before entering the study, all patients 
gave their informed consent to partici-
pate in the study. The study was previ-
ously approved by the Ethics Committee 
of the Ss. Cyril and Methodius Universi-
ty, Medical Faculty, Skopje, Republic of 
North Macedonia. The examination was 
a prospective study. Pregnant women are 
were selected to enter the study between 
their 16-22 g.w. and were being followed 
until the end of the pregnancy. Each 
woman underwent obstetric ultrasound 
by which the gestational week was deter-
mined and it was confirmed that there 
were no exclusion criteria for the patient 
to enter the group of respondents.
The pregnant women were followed on 
Voluson 730pro for ultrasonography. 
Ultrasound cervicometry was done and 
the length of cervix was measured with 
a vaginal transducer. The results were 
recorded in the personal document for 
each patient. Each patient was taken a 
detailed anamnesis adapted to the needs 
and information needed for the research.
After the patient was examined, she was 
hospitalized and prepared for the proce-
dure of amniocentesis. 
The amniocentesis itself took place in 
the ultrasound and diagnostics ward at 
the Department of High Risk Pregnan-
cy. Each amniocentesis was done in spe-
cial sterile conditions with highly deter-
mined protocol and was controlled by 
an ultrasound. It was done in the period 
between 16-22 gestational weeks. Before 
the intervention, the whole procedure 
was described to the patients. A 22 gauge 
spinal needle was inserted into the am-
niotic cavity transabdominally under so-
nographic guidance and 5 ml of amniotic 
fluid was aspirated for the needs of the 
study. Each sterile syringe was marked 
with the name and surname of the pa-
tient, immediately after the interven-
tion. Patients were discharged from hos-
pital on the same day. 
Inclusion criteria: Single pregnancy, pa-
tients who need amniocentesis in their 
early second trimester due to clinical 
indication (advanced mother’s age, ab-
normal test of PRISCA I, suspicious 
anomalies of the fetus, virus infection 
or mother’s wish), pregnancy from 16-22 
gestational week, patients who had no 
signs of miscarriage (spontaneous abor-
tion) while the amniocentesis was being 
made.
Exclusion criteria: Positive test of am-
niocentesis- abnormal karyotype, multi-
ple pregnancies, patients who would not 
be able to be contacted and there would 
be no information on the pregnancy out-
come, confirmed fetal anomalies or pa-
tients where pregnancy was prematurely 
terminated due to other reasons such as 
trauma, preeclampsia, placental abrup-
tion etc. 
Biological samples and their analysis
Amniotic liquid: After amniocentesis, 
the amniotic fluid specimens were cen-
trifuged at 1500 g for 10 min immediate-
ly after collection, and then frozen and 
stored  at − 20°C for further analysis. 
The IL-8 concentration in the amniotic 
liquid was measured by a device - Immu-
lite 2000 HP, Immulite 1000 HP Diag-
nostic Products Corp, at the Institute of 
Immunology and Human Genetics. This 
technique was realized and the analyses 
of the results were done in accordance 
with the manufacturer’s instructions.
Statistical analysis
A database in the statistical program 
SPSS for Windows 23.0 was created for 
the purpose of data statistical analysis 
obtained during the study. The numeri-
cal, i.e. the quantitative parameters were 
shown with an average, standard devi-
ation, median and inter-quarter rank. 
Qualitative i.e. attributive parameters 
are shown by distributing frequencies. 
For comparing women who gave prema-
ture birth with those who gave birth at 
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                 birth
Таble 2.   Cervical length and gestational week at birth 
term, Mann-Whitney test was used. Sta-
tistical significant values were set at the 
value of p<0.05.
Results
This study included 150 patients who un-
derwent amniocentesis during which 5 
ml of amniotic fluid was taken for exam-
ination of IL-8. Also, ultrasound exam-
ination and cervicometry were done. All 
patients were in the period of 16th-22nd 
gestational week. Twenty of the total of 
150 patients gave premature birth, and 
120 gave birth at term. A total of 139 pa-
tients conceived naturally and 9 patients 
underwent IVF and ET. In those with 
IVF and ET, 3 gave preterm birth. 80% 
of patients that had preterm birth had 
increased IL- 8 levels. Median cervical 
length in those who gave birth at term 
was 32.1 and in those who gave preterm 
birth was 30.7.
Nine of all patients had pregnancy with 
IVF and ET. In the group that gave birth 
before 37 weeks of gestation, 15% (3) had 
undergone treatment with IVF and ET. In 
the group that gave birth after 37 weeks 
of gestation, 4.7% (6) had undergone 
treatment with IVF and ET. Differences 
between patients that had IVF and ET 
and those that conceived naturally, and 
the gestational week of delivery were not 
significant (p=0.19) (Table 1). 
Way of 
conceiving
Gestational week at birth
p-leveln At term Preterm 
N (%) N (%)
Normal 139 122 (95.31) 17 (85) X2=1.67
IVF et ET 9 6 (4.69) 3 (15) p=0.19 ns
Term of delivery
Descriptive Statistics 
(cervical length) p-level
n mean ± SD min-max
Term 128 32.12 ± 3.8 22 – 40 t=1.6
Preterm 20 30.7 ± 2.7 27 – 39 p=0.11 ns
Yates Chi-square
T-tests
Cervical length of women who gave preterm birth (< 37 g.w.) was not significantly 
shorter  than that in women who gave birth at term (30.7 ± 2.7 vs.32.12 ± 3.8; p=0.11) 
(Table 2).
Cervical length shorter than 30 mm 
was measured in those women that 
gave birth before 37 weeks of gestation 
(preterm) – 60% (12), opposite of those 
that gave birth at term 40.6% (52). How-
ever, there was no significant difference 
in both groups regarding cervical length. 
It means that in women with cervical 
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9Таble 3.   IL-8 levels and gestational week of delivery
Таble 4.   Differential values of IL-8 in term and preterm patients and their significance 
Figure 1.   IL-8 in term and preterm births
Term at delivery
Descriptive Statistics (IL-8)
p-level
n mean ± SD median (IQR)
Term 128 360.65 ± 459.3 198.2(78.4 – 427.2) Z=5.99
Preterm 20 1585.7 ± 834.7 1598.8(832.5-2251.6) p=0.00000 
IL-8
pg/ml
Term at birth
p-level
n In term N (%)
preterm
N (%)
< 700 113 (88.28) 4 (20)
X2=54.6 
p=0.0000 701 – 1780 11 (8.59) 7 (35)
>1780 4 (3.13) 9 (45)
Mann-Whitney
length longer than 30 mm we found not 
enough evidence for statistically signifi-
cant difference (p=0.1).
Patients that gave preterm birth had sig-
nificantly higher amniotic fluid levels of 
IL -8 in comparison with those that gave 
term birth (p<0.0001) (Table 3). Mean am-
niotic IL-8 level in the preterm group (be-
fore 37 w.g) and at term (after 37 w.g.) was 
1585.7 ± 834.7 and 360.65 ± 459.3 pg/ml, 
respectively. The median was 1598 and 
198 pg/ml, respectively.
Normal range of cytokine IL-8 in am-
niotic fluid was measured in 20% (4) of 
preterm births and 88.3% (113) of term 
births. Higher values, up to 1780 pg/ml, 
were found in 35% (7) of preterm births 
and 8.6% (11) of term births. Higher than 
1780 pg/ml values had 45% (9) of preterm 
births, and3.1% (4) of patients that gave 
term births (Figure 1).
Statistically significant difference was 
registered in those patients whose IL-8 
levels in amniotic fluid were up to 700 
pg/ml to 1780pg/ml and higher than 1780 
pg/ml. There was a statistical confir-
mation as significance (p<0.001) of  IL-8 
levels between groups of patients that 
gave birth at term and those that gave 
preterm births. (Table 4).
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Discussion 
Premature birth is a significant cause 
of neonatal morbidity and mortality 
worldwide, and it places an enormous 
economic burden on healthcare 
resources. Identifying patients at risk 
of preterm delivery at early stage of 
pregnancy is allowing interventions that 
result in lower preterm birth rates and 
associated decrease in neonatal morbidity 
and mortality15. Early diagnosis of 
intraamniotic infection remains a 
problem. To permit intervention, a 
test should detect infection before it 
is clinically apparent. Ideally the test 
should be rapid, simple, inexpensive, and 
capable of being performed in hospital at 
any time of day. Ultimately a valuable test 
must be sufficiently accurate to warrant 
the risks of intervention, particularly at 
early gestational ages2, 16, 17.
Previous authors found that amniotic 
fluid IL-8 levels increase from 17 weeks to 
pregnancy until term18, 19, 20. A peak in 
mean amniotic fluid IL-8 concentration 
was found at about 22 weeks of gestation 
followed by decline, which resulted in 
a mean concentration of 460 pg/ml at 
term21. An increased  amniotic fluid IL-8 
level has been found by others to be as 
accurate as or more accurate than that 
of gram stain for the early detection 
of intraamniotic infection in the 
symptomatic patients with spontaneous 
preterm delivery22. With a threshold 
of 700 pg/ml, Romero et al. found a 
sensitivity of 87% compared to 65% of 
the gram stain23, whereas Kirshon and 
Rosenfeld reported 91% sensitivity at 
1800 pg/ml threshold compared to 66% 
of the gram stain24. While amniotic 
fluid IL-8 levels seem to serve as an 
index of intraamniotic infection during 
the peripartum period in preterm and 
term pregnancies, their possible value 
as a diagnostic tool in earlier phases of 
pregnancy is still uncertain9,15,17,25,26. 
However, in some recent studies 
subclinical intrauterine inflammatory 
cytokine response such as increased 
CRP, IL-6, matrix metalloproteinases and 
angiogenin concentration already might 
be present very early in the gestation27. 
The relative risk of preterm delivery in 
the presence of elevated concentrations 
of inflammation markers (IL-6, CRP, 
TNF-a, angiogenin) at the time of genetic 
amniocentesis has been consistently 
reported to be elevated28.
The results obtained in this study, 
support the expected hypothesis that 
the increased IL-8 in the amniotic fluid, 
although in asymptomatic patients, still 
affects the outcome of the pregnancy i.e. 
its increase leads to premature birth. 
The examination is more valuable since 
we know that 5-18% in total of the full 
number of births in our Clinic belongs to 
this group. The results have confirmed 
that risk factors for premature birth 
include shortened cervix (Table 2) 
and presence of increased values of 
the inflammatory marker IL- 8 in the 
amniotic fluid.In the group of patients 
who gave premature birth, the average 
value of gestational week was from 
32nd to 36th, whereas in the group 
with normal values, the most common 
findings showed delivery on time, i.e. in 
the 37th gestational week (Figure 1). The 
examinations in which amniotic fluid 
is used for researches of cytokines, are 
relatively new and done to a small series 
of patients29. In the examined group, 
changes have been observed in other 
parameters i.e. the cervical length, but 
not in the number of leukocytes, and 
the values of glucose in the amniotic 
liquid which suggests that the increased 
cytokines i.e. IL-8 as a risk factor affect 
the outcome and time of giving birth30. 
However, a large amount of research has 
been devoted to determining risk factors 
and predictors of preterm delivery and 
while advances have been made, no 
single method has been identified that 
can consistently predict which patients 
will delivery prematurely2,17,31.
Conclusion 
This study is the first one done in 
Republic of North Macedonia aimed at 
examining any kind of changes in the 
amniotic fluid, regardless of gestational 
age. The study has so far confirmed 
the reason for examining cytokines as 
a method to discover asymptomatic 
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changes in patients who would give a 
premature birth. To date, there have 
been few studies that have addressed 
the same hypothesis. The increased 
levels of IL-8 connected with preterm 
birth in the pathophysiological pathways 
may provide an understanding as to 
why various therapeutic interventions 
succeed in some people and fail in others. 
They may also explain differences in 
sensitivity to various stimuli that trigger 
preterm labor. If these results are true, 
then the implication is that there are 
innate and differentially distributed risk 
factors among populations with respect 
to immune responses.
The further course of the study will 
additionally determine the values and 
frequency of changes in premature 
birth. The expected results are those 
shown in patients who do have certain 
inflammatory agent (increased IL-8), 
shortened cervix and will have more 
common complications i.e. it would be 
expected that there is an increased risk 
of a premature birth. The benefit of the 
study lies in detecting asymptomatic 
cases, so that this complication can 
be prevented on time. This type of 
examination would contribute to 
reduction of premature births, which 
goes along with a high rate of morbidity 
and mortality as well as high costs at the 
Clinic regarding these complications. It 
would be useful to create an algorithm 
for multidisciplinary treatment of these 
patients. These results should provide 
fertile grounds for further research in 
this area.
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